51 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
of Governors.
(zz) Insurance. The Company carries, or is covered by, insurance (issued by insurers of recognized financial responsibility) in such amounts … the Representative nor any other Underwriter has assumed an advisory or fiduciary responsibility in favor of the Company with respect to the Offering
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
contained in any permitted free writing prospectuses we have authorized for use in connection with this offering. We take no responsibility for, and can … information is the responsibility of management and has been prepared in good faith on a consistent basis with prior periods. However, we have not completed
8-K
CGTX
Cognition Therapeutics Inc
11 Mar 24
Results of Operations and Financial Condition
4:11pm
procedures. This preliminary financial information is the responsibility of management and has been prepared in good faith on a consistent basis
424B5
05vmpev60tqljfq4anmn
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
fvllwu3zah894ouxnqu
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
dyl6vbs
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
htcsy0qhd1k
23 Dec 22
Shelf registration
4:16pm
S-3
EX-4.4
i3bcmdn6l9y 17u67f
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
61w7un 994q
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
f3r3vvblw0cqjb
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
d3p3eiep
20 Oct 22
Draft registration statement
12:00am
DEF 14A
4pq0gjo hmq4
25 Apr 22
Definitive proxy
5:28pm
10-K
dtb3lsr
30 Mar 22
Annual report
7:40am
10-Q
x9re gfy175
17 Nov 21
Quarterly report
5:15pm